CePA: Novel nanomedicine for alleviating MASH via mTOR repression

  • Post author:
  • Post category:uncategorized

Metabolic dysfunction-associated steatohepatitis (MASH) is one of the most common chronic liver diseases, primarily caused by metabolic disorders and systemic inflammatory responses.